Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

New antiinflammatory and analgesic compounds in development at Roche

March 5, 1998

Idec, SKB announce development plans for clenoliximab

March 3, 1998

Boehringer Ingelheim reveals new antiinflammatory agents

March 3, 1998

AutoImmune will conduct pivotal study of Colloral

Feb. 27, 1998

Beneficial effects of FK-506 in animal model of rheumatoid arthritis

Feb. 27, 1998

Orthovisc PMA accepted for filing by FDA

Feb. 25, 1998

Selective inhibitor of p38 MAP kinase effective in chronic inflammatory diseases

Feb. 25, 1998

Flobufen update

Feb. 24, 1998

First phase II results reported for EuroAlliance's DAAID

Feb. 23, 1998

Patent coverage for Idec's humanized antibody for SLE

Feb. 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...